首页> 外文期刊>Genomics >The androgen receptor expression and association with patients survival in different cancers
【24h】

The androgen receptor expression and association with patients survival in different cancers

机译:雄激素受体表达与患者在不同癌症中存活的关联

获取原文
           

摘要

To understand the androgen receptor (AR) in different human malignancies, we conducted a pan-cancer analysis of AR in different tumor tissues and association with patient survival and obtained AR expression data from The Cancer Genome Atlas. Pan-Cancer Analysis of AR indicated that 12 tumor types had decreased AR expression in the tumor, while glioblastoma multiforme has overexpressed AR. The survival analysis showed that high AR mRNA is associated with poor survival of stomach adenocarcinoma and low-grade glioma, but better survival of adrenocortical carcinoma, kidney renal clear cell carcinoma, acute myeloid leukemia, liver hepatocellular carcinoma, ovarian serous cystadenocarcinoma, and skin cutaneous melanoma based on AR mRNA, protein or AR-score. AR was associated with different clinical characteristics and AR correlated genes enriched in cancer-related pathways. These data indicate that AR signaling may be strongly associated with some cancer development and patients survival, which is promising for potential treatment using antiandrogen therapies.
机译:为了了解不同人类恶性肿瘤中的雄激素受体(AR),我们在不同肿瘤组织中进行了泛癌癌症分析,并与患者存活相关联,并从癌症基因组地图集获得AR表达数据。 AR的泛癌分析表明,12种肿瘤类型在肿瘤中有表达降低,而胶质母细胞瘤多形状具有过表达的AR。生存分析表明,高AR mRNA与胃腺癌和低级胶质瘤的存活率不良,但更好地存活肾上腺皮质癌,肾肾透明细胞癌,急性髓性白血病,肝脏肝细胞癌,卵巢浆液性膀胱瘤,皮肤皮肤基于Ar mRNA,蛋白质或AR分数的黑色素瘤。 AR与癌症相关途径中富集的不同临床特征和富相关基因有关。这些数据表明AR信号传导可能与某些癌症发育和患者存活率强烈相关,这是使用抗抗原疗法的潜在治疗的潜在治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号